Immatics (NASDAQ:IMTX) Azioni, Quote.MetaTitle.unusual-options

Immatics

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Vendite allo scoperto

Rapporto azionario

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Comments

Immatics Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO